Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcomeCumali Efe, Staffan Wåhlin, Mårten Werner et al.|Journal of Gastroenterology and Hepatology|2020Cited by 68
X Chromosome Contribution to the Genetic Architecture of Primary Biliary CholangitisRosanna Asselta, Pietro Andreoné, Elvezia Maria Paraboschi et al.|Gastroenterology|2021Cited by 53
Validation of Risk Scoring Systems in Ursodeoxycholic Acid–Treated Patients With Primary Biliary CholangitisCumali Efe, Staffan Wåhlin, Koray Taşçılar et al.|The American Journal of Gastroenterology|2019Cited by 48
Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agentsBenedetta Terziroli Beretta‐Piccoli, Luigi Muratori, Claudia Di Bartolomeo et al.|Journal of Autoimmunity|2019Cited by 24
Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP surveySavino Bruno, V. Di Marco, S. Bollani et al.|Digestive and Liver Disease|2014Cited by 1